Global Nucleic Acid Aptamers Market: Overview
Aptamers are peptides or oligonucleotide molecules that bond with a specific target molecule. Nucleic acid aptamers are a special class of nucleic acid species created via rounds of in-vitro selection or SELEX (systematic evolution of ligands by exponential enrichment). Nucleic acid aptamers help in binding various molecular targets such as proteins, cells, tissues, and organisms. They also assist in molecular recognition of certain characters that fight antibodies and, as a result, are quickly emerging as a possible alternative to commonly used biomolecule, antibodies.
Nucleic acid aptamers are not only distinctly recognizable, they also offer other advantages over antibodies, such as the possibility to be synthesized completely in a test tube, desirable storage properties, and extremely little immunogenicity in therapeutic applications. Concurrently, the global market for nucleic acid aptamers is projected for a robust CAGR during the forecast period of 2016 to 2023.
The global nucleic acid aptamers market can be segmented on the basis of type of technology and application. Some of the most prominent technologies are oligonucleotide synthesis, bioinformatics and next generation sequencing, modified oligonucleotides, nanoparticles and quantum dot labels, surface plasmon resonance and biolayer inferometry. By application, the market can be categorized as diagnostics and therapeutics. The diagnostics segment is further classified as application in human clinical diagnostic assays, veterinary diagnostics, and environmental monitoring. The therapeutics market is segmented on the basis of the currently available aptamer drugs, drug delivery in cancer therapy, various conditions targeted by aptamer drugs, and use of aptamers in modification of surgical implants.
Global Nucleic Acid Aptamers Market: Trends and Opportunities
The application of aptamers in therapeutics, diagnostics, and research is on the rise as they exhibit enhanced effectiveness, which is driving the global market for nucleic acid aptamers. Favorable policies by several governments across the globe for conducting clinical trials and research is also encouraging market expansion. Another factor expected to positively impact the global market for nucleic acid aptamers is their low manufacturing cost, which makes them ideal for the treatment of common life-threatening diseases such as cancer, HIV/AIDS, and other autoimmune diseases. Additionally, patent expiration of SELEX open new opportunities for players.
Conversely, unfavorable government regulations in European countries is expected to hinder the growth of the market for nucleic acid aptamers in the region. Moreover, the market is facing similar challenges in developing countries such as India and China, coupled with poor response from consumers due to ethical issues. This factor is curtailing the growth rate in the vastly populated Asia Pacific region. Lack of trained professionals is another restraining factor for the market.
Global Nucleic Acid Aptamers Market: Region-wise Outlook
Due to robust healthcare infrastructure, high adoption rate of new technology, and favorable government policies in the regional market for nucleic acid aptamers, North America currently dominates the demand and is expected to remain most lucrative during the forecast period. However, Asia Pacific is projected for healthy growth due to vast populations and increased government initiatives towards improving medical facilities.
Companies mentioned in the research report
Some of the prominent companies in the global market for nucleic acid aptamers are Araxis Kits, LLC, Aptamer Sciences, Inc., Aptagen, LLC, Envirologix, Inc., Cytogenix Inc., Mitsui & Co. Inc., and Quest Diagnostics.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.